NVAX
Novavax, Inc. NASDAQ Listed Dec 5, 1995$9.13
-3.89%
vs $9.50
Mkt Cap $1.6B
52w Low $6.22
58.6% of range
52w High $11.19
50d MA $9.05
200d MA $8.47
P/E (TTM)
3.6x
EV/EBITDA
2.2x
P/B
—
Debt/Equity
-1.9x
ROE
-344.6%
P/FCF
-6.3x
RSI (14)
27.80
ATR (14)
$0.59
Beta
2.65
50d MA
$9.05
200d MA
$8.47
Avg Volume
5.7M
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
21 Firstfield Road · Gaithersburg, MD 20878 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | BMO | -0.66 | 0.11 | +116.7% | 11.19 | -0.4% | -9.4% | -0.3% | -6.1% | +4.2% | +1.0% | — |
| Nov 6, 2025 | BMO | -1.08 | -0.62 | +42.6% | 7.59 | -1.6% | -2.0% | -4.4% | +4.6% | -3.2% | -1.9% | — |
| Aug 6, 2025 | BMO | -0.07 | 0.62 | +985.7% | 7.58 | +0.4% | +15.8% | -4.7% | -4.1% | +5.6% | +4.4% | — |
| May 8, 2025 | BMO | 0.71 | 2.93 | +312.7% | 6.66 | -0.8% | -10.2% | +6.0% | -2.4% | -3.7% | +5.5% | — |
| Feb 27, 2025 | BMO | -0.75 | -0.51 | +32.0% | 7.06 | +1.6% | +18.0% | -5.5% | -2.4% | +2.7% | -0.3% | — |
| Nov 12, 2024 | BMO | -0.87 | -0.76 | +12.6% | 8.46 | -0.2% | -8.2% | -7.1% | +1.4% | +7.0% | +2.2% | — |
| Aug 8, 2024 | BMO | 1.64 | 0.99 | -39.6% | 11.68 | -0.9% | -0.7% | +2.2% | +2.6% | +0.2% | +3.7% | — |
| May 10, 2024 | BMO | -1.04 | -1.05 | -1.0% | 8.88 | +9.1% | +47.6% | +2.8% | -4.3% | +11.6% | -9.7% | — |
| Feb 28, 2024 | BMO | -0.49 | -1.44 | -193.9% | 4.41 | -0.2% | +12.0% | +9.1% | +1.9% | +1.5% | +0.7% | — |
| Nov 9, 2023 | BMO | -1.82 | -1.26 | +30.8% | 6.71 | -0.4% | -7.0% | +0.5% | -0.5% | -0.6% | -6.0% | — |
| Aug 8, 2023 | BMO | -1.39 | 0.58 | +141.7% | 7.23 | +2.9% | -1.5% | +8.0% | -4.3% | -1.6% | +0.0% | — |
| May 9, 2023 | BMO | -3.38 | -3.41 | -0.9% | 9.52 | +5.1% | -5.6% | -1.1% | -4.9% | -4.0% | -5.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.19 | $11.15 | -0.4% | -9.4% | -0.3% | -6.1% | +4.2% | +1.0% |
| Jan 20 | BTIG | Maintains | Buy → Buy | — | $8.01 | $8.22 | +2.6% | +2.4% | +20.7% | -1.5% | -5.9% | +5.0% |
| Nov 18 | JP Morgan | Maintains | Underweight → Underweight | — | $6.80 | $6.61 | -2.8% | -3.4% | -3.5% | -1.9% | +4.0% | +2.5% |
| Nov 10 | B. Riley Securities | Maintains | Buy → Buy | — | $7.44 | $7.56 | +1.6% | -4.4% | +4.6% | -3.2% | -1.9% | -1.3% |
| Nov 4 | TD Cowen | Maintains | Hold → Hold | — | $7.91 | $7.69 | -2.8% | -5.1% | +2.4% | -1.3% | -2.0% | -4.4% |
| Oct 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.46 | $8.48 | +0.2% | -1.2% | +1.9% | +2.1% | -2.1% | -1.6% |
| Aug 20 | BofA Securities | Downgrade | Neutral → Underperform | — | $9.52 | $8.72 | -8.4% | -8.2% | -12.7% | +2.8% | -4.1% | -0.3% |
| Jul 22 | BofA Securities | Maintains | Neutral → Neutral | — | $7.17 | $7.19 | +0.3% | +0.7% | +8.6% | -2.6% | -2.2% | -2.5% |
| May 9 | JP Morgan | Maintains | Underweight → Underweight | — | $6.66 | $6.61 | -0.8% | -10.2% | +6.0% | -2.4% | -3.7% | +5.5% |
| Dec 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.07 | $9.10 | +0.3% | -3.3% | +0.6% | +2.3% | +1.0% | +1.3% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.46 | $8.44 | -0.2% | -8.2% | -7.1% | +1.4% | +7.0% | +2.2% |
| Nov 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.01 | $8.05 | -10.7% | -6.1% | -8.2% | -7.1% | +1.4% | +7.0% |
| Aug 12 | JP Morgan | Maintains | Underweight → Underweight | — | $11.60 | $11.38 | -1.9% | +2.2% | +2.6% | +0.2% | +3.7% | +2.5% |
| Aug 12 | B. Riley Securities | Maintains | Buy → Buy | — | $11.60 | $11.38 | -1.9% | +2.2% | +2.6% | +0.2% | +3.7% | +2.5% |
| Aug 2 | B. Riley Securities | Maintains | Buy → Buy | — | $12.57 | $11.93 | -5.1% | -6.3% | -3.4% | +1.3% | -7.1% | +9.1% |
| Jul 30 | JP Morgan | Downgrade | Neutral → Underweight | — | $16.42 | $14.44 | -12.1% | -25.7% | +5.0% | -1.9% | -6.3% | -3.4% |
| Jun 14 | BofA Securities | Maintains | Neutral → Neutral | — | $15.05 | $14.32 | -4.9% | -4.3% | -2.4% | -1.9% | +2.0% | -0.4% |
| May 23 | B. Riley Securities | Maintains | Buy → Buy | — | $15.70 | $16.16 | +2.9% | -3.5% | +2.3% | +0.1% | -2.6% | +0.9% |
| May 13 | TD Cowen | Maintains | Hold → Hold | — | $8.88 | $9.69 | +9.1% | +47.6% | +2.8% | -4.3% | +11.6% | -9.7% |
| May 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.88 | $9.69 | +9.1% | +47.6% | +2.8% | -4.3% | +11.6% | -9.7% |
| May 10 | BofA Securities | Upgrade | Underperform → Neutral | — | $4.47 | $10.02 | +124.2% | +98.7% | +47.6% | +2.8% | -4.3% | +11.6% |
| Mar 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.94 | $5.09 | +3.0% | +9.1% | +1.9% | +1.5% | +0.7% | +0.0% |
| Feb 23 | B. Riley Securities | Maintains | Buy → Buy | — | $4.88 | $5.06 | +3.7% | +8.4% | +4.0% | +9.5% | -26.7% | +12.0% |
| Aug 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.12 | $7.16 | +0.6% | +8.0% | -4.3% | -1.6% | +0.0% | -1.5% |
| Aug 9 | B. Riley Securities | Upgrade | Neutral → Buy | — | $7.23 | $7.44 | +2.9% | -1.5% | +8.0% | -4.3% | -1.6% | +0.0% |
| May 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.52 | $10.01 | +5.1% | -5.6% | -1.1% | -4.9% | -4.0% | -5.8% |
| Mar 1 | B. Riley Securities | Downgrade | Buy → Neutral | — | $9.26 | $6.83 | -26.2% | -25.9% | +1.0% | +11.0% | -5.2% | -4.4% |
| Feb 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.88 | $10.02 | +1.4% | -1.0% | +1.5% | +2.6% | -2.0% | +0.3% |
| Jan 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Oct 14 | B. Riley Securities | Maintains | Buy → Buy | — | $21.28 | $21.50 | +1.0% | -7.6% | +3.3% | -8.4% | -3.7% | -4.2% |
| Sep 22 | JP Morgan | Downgrade | Neutral → Underweight | — | $25.87 | $24.63 | -4.8% | -13.3% | -6.4% | -10.1% | +6.2% | -2.1% |
| Aug 9 | TD Cowen | Maintains | Outperform → Outperform | — | $57.25 | $39.98 | -30.2% | -29.6% | +2.7% | -2.5% | +2.8% | +2.0% |
| Jun 8 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $47.54 | $52.31 | +10.0% | +5.4% | -17.2% | -2.1% | -10.7% | +6.7% |
| May 20 | BofA Securities | Maintains | Underperform → Underperform | — | $58.43 | $55.71 | -4.7% | -8.6% | -3.8% | -9.5% | -0.9% | +2.0% |
| Apr 26 | B. Riley Securities | Maintains | Buy → Buy | — | $50.21 | $50.00 | -0.4% | -5.6% | -2.0% | -4.7% | +1.8% | +19.3% |
| Mar 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $86.39 | $85.48 | -1.1% | -6.8% | -10.9% | -2.8% | +4.4% | +8.6% |
| Jan 21 | TD Cowen | Maintains | Outperform → Outperform | — | $90.36 | $87.36 | -3.3% | -6.3% | -6.1% | -2.8% | +2.6% | -7.9% |
| Dec 21 | JP Morgan | Maintains | Neutral → Neutral | — | $201.95 | $193.01 | -4.4% | -5.4% | -4.1% | -3.3% | -11.0% | -1.2% |
| Jun 15 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $207.71 | $200.00 | -3.7% | -9.9% | -5.8% | +2.1% | -3.0% | +3.8% |
| May 12 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $138.18 | $132.50 | -4.1% | -7.5% | -5.3% | +8.8% | +6.4% | +3.1% |
| May 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $138.18 | $132.50 | -4.1% | -7.5% | -5.3% | +8.8% | +6.4% | +3.1% |
| May 12 | JP Morgan | Downgrade | Overweight → Neutral | — | $138.18 | $132.50 | -4.1% | -7.5% | -5.3% | +8.8% | +6.4% | +3.1% |
| Mar 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $187.63 | $213.51 | +13.8% | +8.1% | +7.2% | +2.2% | +1.5% | -3.6% |
| Feb 18 | B. Riley FBR | Maintains | Buy → Buy | — | $273.98 | $271.99 | -0.7% | -3.2% | +4.7% | -11.8% | -0.8% | -1.4% |
| Feb 18 | B. Riley Securities | Maintains | Buy → Buy | — | $273.98 | $271.99 | -0.7% | -3.2% | +4.7% | -11.8% | -0.8% | -1.4% |
| Feb 17 | B. Riley FBR | Maintains | Buy → Buy | — | $262.70 | $249.20 | -5.1% | +4.3% | -3.2% | +4.7% | -11.8% | -0.8% |
| Feb 5 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $280.92 | $283.62 | +1.0% | +3.3% | +10.3% | -1.3% | -5.5% | -0.0% |
| Feb 1 | B. Riley FBR | Maintains | Buy → Buy | — | $220.94 | $242.52 | +9.8% | +21.4% | -1.4% | +7.5% | -1.2% | +3.3% |
| Feb 1 | B. Riley Securities | Maintains | Buy → Buy | — | $220.94 | $242.52 | +9.8% | +21.4% | -1.4% | +7.5% | -1.2% | +3.3% |
| Jan 31 | B. Riley FBR | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
No insider trades available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Shah Capital Management | 14,845,097 | $121M | Added | Mar 2026 |
| 2 | D.e. Shaw & Co | 7,709,858 | $63M | Added | Mar 2026 |
| 3 | Vanguard Portfolio Management Llc | 7,151,625 | $58M | New | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 7,130,147 | $58M | New | Mar 2026 |
| 5 | Bank Of America Corp /de/ | 6,637,213 | $54M | Added | Mar 2026 |
| 6 | Morgan Stanley | 7,435,968 | $50M | Added | Dec 2025 |
| 7 | Ubs Group Ag | 4,477,701 | $36M | Reduced | Mar 2026 |
| 8 | Millennium Management | 3,852,545 | $31M | Reduced | Mar 2026 |
| 9 | Coatue Management | 3,836,986 | $31M | New | Mar 2026 |
| 10 | Point72 Asset Management | 1,518,211 | $12M | Added | Mar 2026 |
| 11 | Northern Trust Corp | 1,509,326 | $12M | Added | Mar 2026 |
| 12 | Barclays Plc | 1,191,079 | $10M | Added | Mar 2026 |
| 13 | Marshall Wace, Llp | 1,166,197 | $9M | Added | Mar 2026 |
| 14 | Citadel Advisors Llc | 1,123,746 | $9M | Added | Mar 2026 |
| 15 | Monaco Asset Management Sam | 1,045,000 | $7M | Added | Dec 2025 |
| 16 | Susquehanna International Group, Llp | 834,842 | $7M | Added | Mar 2026 |
| 17 | Bank Of New York Mellon Corp | 780,797 | $6M | Reduced | Mar 2026 |
| 18 | Two Sigma Investments, Lp | 614,799 | $5M | Reduced | Mar 2026 |
| 19 | Edgestream Partners, L.p. | 520,135 | $4M | New | Mar 2026 |
| 20 | Fmr Llc | 500,817 | $4M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.58B
Enterprise Value
$1.09B
P/E (TTM)
3.59x
Forward P/E
—
PEG Ratio
-0.01x
P/B
—
P/S
1.41x
P/FCF
-6.32x
EV/EBITDA
2.22x
Shares Out
173.1M
Financials (TTM)
Revenue
$1.12B
Net Income
$440.3M
EBITDA
$492.3M
Free Cash Flow
-$250.2M
Op Cash Flow
-$244.6M
EPS Basic
$2.72
EPS Diluted
$2.54
EPS Forward
$-0.40
Gross Margin
93.7%
Op Margin
50.1%
Net Margin
39.2%
Balance Sheet
Total Assets
$1.18B
Total Liab.
$1.30B
Total Equity
-$127.8M
Cash
$735.1M
LT Debt
$246.3M
Book Value/Sh
$-0.79
Debt/Equity
-1.95x
Current Ratio
2.13
Quick Ratio
2.10
Returns & Growth
ROE
-344.6%
ROA
37.4%
ROIC
78.0%
Rev Growth YoY
+64.7%
EPS Growth YoY
+321.1%
Price Returns
2W
+17.3%
1M
+38.3%
3M
+8.2%
6M
+55.6%
12M
+49.5%
Technicals
52W High
$11.19
52W Low
$6.22
50d MA
$9.05
200d MA
$8.47
RSI (14)
27.80
ATR (14)
$0.59
Beta
2.65
Avg Volume
5.7M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
12
Ex-Div Date
Dec 13, 2007
Analyst Price Targets
Consensus
$18.00
High
$25.00
Low
$11.00
Median
$18.00
Data updated apr 26, 2026 4:13pm
· Source: financialmodelingprep.com